CN114917160A - 一种具有抗氧化、抗炎、修护功效的香水莲花发酵物及其制备与应用 - Google Patents
一种具有抗氧化、抗炎、修护功效的香水莲花发酵物及其制备与应用 Download PDFInfo
- Publication number
- CN114917160A CN114917160A CN202210631263.7A CN202210631263A CN114917160A CN 114917160 A CN114917160 A CN 114917160A CN 202210631263 A CN202210631263 A CN 202210631263A CN 114917160 A CN114917160 A CN 114917160A
- Authority
- CN
- China
- Prior art keywords
- nymphaea hybrid
- fermentation
- inflammatory
- nymphaea
- antioxidant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000209490 Nymphaea Species 0.000 title claims abstract description 126
- 238000000855 fermentation Methods 0.000 title claims abstract description 103
- 230000004151 fermentation Effects 0.000 title claims abstract description 103
- 230000000694 effects Effects 0.000 title claims abstract description 56
- 230000003110 anti-inflammatory effect Effects 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 26
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 24
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims abstract description 49
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims abstract description 48
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims abstract description 48
- 238000000034 method Methods 0.000 claims abstract description 41
- 239000002537 cosmetic Substances 0.000 claims abstract description 13
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 claims abstract 8
- 239000001963 growth medium Substances 0.000 claims description 77
- 239000000047 product Substances 0.000 claims description 63
- 239000007788 liquid Substances 0.000 claims description 53
- 239000000706 filtrate Substances 0.000 claims description 25
- 239000000284 extract Substances 0.000 claims description 23
- 239000002609 medium Substances 0.000 claims description 23
- 238000001914 filtration Methods 0.000 claims description 22
- 230000002779 inactivation Effects 0.000 claims description 19
- 239000003755 preservative agent Substances 0.000 claims description 18
- 239000007787 solid Substances 0.000 claims description 18
- 230000002335 preservative effect Effects 0.000 claims description 16
- 230000004913 activation Effects 0.000 claims description 14
- 238000009630 liquid culture Methods 0.000 claims description 14
- 230000001580 bacterial effect Effects 0.000 claims description 11
- 239000000725 suspension Substances 0.000 claims description 11
- 239000012528 membrane Substances 0.000 claims description 10
- 238000011218 seed culture Methods 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 8
- -1 polypropylene Polymers 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 7
- 239000004743 Polypropylene Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 238000001471 micro-filtration Methods 0.000 claims description 7
- 229920001155 polypropylene Polymers 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 5
- 238000009928 pasteurization Methods 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- KWIPUXXIFQQMKN-UHFFFAOYSA-N 2-azaniumyl-3-(4-cyanophenyl)propanoate Chemical compound OC(=O)C(N)CC1=CC=C(C#N)C=C1 KWIPUXXIFQQMKN-UHFFFAOYSA-N 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 2
- 229940090948 ammonium benzoate Drugs 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 235000007650 Aralia spinosa Nutrition 0.000 claims 1
- 241000949456 Zanthoxylum Species 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 abstract description 36
- 229920001282 polysaccharide Polymers 0.000 abstract description 36
- 239000005017 polysaccharide Substances 0.000 abstract description 36
- 150000001413 amino acids Chemical class 0.000 abstract description 19
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 18
- 235000013824 polyphenols Nutrition 0.000 abstract description 18
- 210000003491 skin Anatomy 0.000 abstract description 14
- 241001312894 Trollius chinensis Species 0.000 abstract description 10
- 230000008439 repair process Effects 0.000 abstract description 10
- 239000004480 active ingredient Substances 0.000 abstract description 9
- 230000003647 oxidation Effects 0.000 abstract description 6
- 238000007254 oxidation reaction Methods 0.000 abstract description 6
- 241000612118 Samolus valerandi Species 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 210000004207 dermis Anatomy 0.000 abstract description 3
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 50
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 40
- 210000004027 cell Anatomy 0.000 description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 27
- 210000002510 keratinocyte Anatomy 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000000203 mixture Substances 0.000 description 24
- 238000012360 testing method Methods 0.000 description 22
- 230000001954 sterilising effect Effects 0.000 description 18
- 239000000523 sample Substances 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000002158 endotoxin Substances 0.000 description 13
- 229920006008 lipopolysaccharide Polymers 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 235000006708 antioxidants Nutrition 0.000 description 12
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 12
- 229960001031 glucose Drugs 0.000 description 12
- 230000002757 inflammatory effect Effects 0.000 description 12
- RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 description 12
- 229960001920 niclosamide Drugs 0.000 description 12
- 230000004888 barrier function Effects 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 108090001005 Interleukin-6 Proteins 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 108090001007 Interleukin-8 Proteins 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- 239000001888 Peptone Substances 0.000 description 8
- 108010080698 Peptones Proteins 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 235000019319 peptone Nutrition 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 102100028314 Filaggrin Human genes 0.000 description 7
- 101000917159 Homo sapiens Filaggrin Proteins 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 101000827746 Homo sapiens Fibroblast growth factor receptor 1 Proteins 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 6
- 229960005091 chloramphenicol Drugs 0.000 description 6
- 230000031700 light absorption Effects 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 239000012488 sample solution Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 238000003809 water extraction Methods 0.000 description 6
- 102100031784 Loricrin Human genes 0.000 description 5
- 244000061456 Solanum tuberosum Species 0.000 description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 101000976051 Homo sapiens Involucrin Proteins 0.000 description 4
- 240000002853 Nelumbo nucifera Species 0.000 description 4
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 4
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 4
- 241000588769 Proteus <enterobacteria> Species 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000003828 downregulation Effects 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 229920002521 macromolecule Polymers 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 108020000318 saccharopine dehydrogenase Proteins 0.000 description 4
- 239000013535 sea water Substances 0.000 description 4
- 230000008591 skin barrier function Effects 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 108010058734 transglutaminase 1 Proteins 0.000 description 4
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 4
- 102100036621 Glucosylceramide transporter ABCA12 Human genes 0.000 description 3
- 101000929652 Homo sapiens Glucosylceramide transporter ABCA12 Proteins 0.000 description 3
- 102100023913 Involucrin Human genes 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002212 flavone derivatives Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 2
- 101150038907 ABCA12 gene Proteins 0.000 description 2
- 108091005658 Basic proteases Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000282376 Panthera tigris Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 240000005499 Sasa Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000011712 cell development Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229940047122 interleukins Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- QDBBZVMXWVKHPI-UHFFFAOYSA-N n-chloronitramide Chemical compound [O-][N+](=O)NCl QDBBZVMXWVKHPI-UHFFFAOYSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000031990 negative regulation of inflammatory response Effects 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- SFAYBQDGCKZKMH-UHFFFAOYSA-N BNCC Chemical compound BNCC SFAYBQDGCKZKMH-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 101150027725 IVL gene Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100030944 Protein-glutamine gamma-glutamyltransferase K Human genes 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 102000002932 Thiolase Human genes 0.000 description 1
- 108060008225 Thiolase Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 108010075526 keratohyalin Proteins 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- JLYXXMFPNIAWKQ-UHFFFAOYSA-N γ Benzene hexachloride Chemical compound ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl JLYXXMFPNIAWKQ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210631263.7A CN114917160B (zh) | 2022-06-06 | 2022-06-06 | 一种具有抗氧化、抗炎、修护功效的香水莲花发酵物及其制备与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210631263.7A CN114917160B (zh) | 2022-06-06 | 2022-06-06 | 一种具有抗氧化、抗炎、修护功效的香水莲花发酵物及其制备与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114917160A true CN114917160A (zh) | 2022-08-19 |
CN114917160B CN114917160B (zh) | 2023-09-08 |
Family
ID=82811706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210631263.7A Active CN114917160B (zh) | 2022-06-06 | 2022-06-06 | 一种具有抗氧化、抗炎、修护功效的香水莲花发酵物及其制备与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114917160B (zh) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104509901A (zh) * | 2013-09-27 | 2015-04-15 | 青岛畅绿生物研究所 | 一种睡莲植物益生菌多味健康饮品 |
CN106879898A (zh) * | 2017-03-20 | 2017-06-23 | 甘肃农业大学 | 一种提高乳酸发酵饮料中黄酮和多酚含量的方法 |
KR20170137963A (ko) * | 2016-06-03 | 2017-12-14 | 인코스(주) | 씀바귀, 선복화 및 민들레를 유산균으로 발효한 항염활성, 피부개선에 유용한 발효 추출물 및 이를 이용한 화장료 조성물 |
CN109303734A (zh) * | 2018-12-13 | 2019-02-05 | 北京天奇益人健康科技有限公司 | 一种香水莲花提取物及其在制备化妆品中的应用 |
KR20190037436A (ko) * | 2017-09-29 | 2019-04-08 | (주)지에프씨생명과학 | 수련 발효 추출물을 함유하는 화장료 조성물 및 이의 제조방법 |
CN110237003A (zh) * | 2019-07-10 | 2019-09-17 | 西双版纳宝翠香莲生物科技有限公司 | 一种香水莲花提取物及其在护肤品中的应用 |
CN110251433A (zh) * | 2019-07-11 | 2019-09-20 | 广州栋方生物科技股份有限公司 | 一种香水莲花提取物及其制备方法、包含其的香水莲花水以及莲花保湿舒敏水 |
CN110420143A (zh) * | 2019-08-28 | 2019-11-08 | 青蛙王子(福建)婴童护理用品有限公司 | 一种含有九品香水莲花提取物的凝露及其制备方法 |
KR102167786B1 (ko) * | 2020-07-28 | 2020-10-19 | 주식회사 토리든 | 락토바실러스를 이용한 병풀, 접시꽃, 푸른연꽃, 쓴풀 화장료용 발효물 및 그 제조방법과 화장료용 발효물을 함유한 상처치유, 피부 재생, 진정, 및 항염 효능을 갖는 화장료 조성물 |
CN112168727A (zh) * | 2020-09-29 | 2021-01-05 | 上海怡宝化妆品集团有限公司 | 一种含有灵芝子实体孢子粉发酵液的精华及其制备方法 |
-
2022
- 2022-06-06 CN CN202210631263.7A patent/CN114917160B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104509901A (zh) * | 2013-09-27 | 2015-04-15 | 青岛畅绿生物研究所 | 一种睡莲植物益生菌多味健康饮品 |
KR20170137963A (ko) * | 2016-06-03 | 2017-12-14 | 인코스(주) | 씀바귀, 선복화 및 민들레를 유산균으로 발효한 항염활성, 피부개선에 유용한 발효 추출물 및 이를 이용한 화장료 조성물 |
CN106879898A (zh) * | 2017-03-20 | 2017-06-23 | 甘肃农业大学 | 一种提高乳酸发酵饮料中黄酮和多酚含量的方法 |
KR20190037436A (ko) * | 2017-09-29 | 2019-04-08 | (주)지에프씨생명과학 | 수련 발효 추출물을 함유하는 화장료 조성물 및 이의 제조방법 |
CN109303734A (zh) * | 2018-12-13 | 2019-02-05 | 北京天奇益人健康科技有限公司 | 一种香水莲花提取物及其在制备化妆品中的应用 |
CN110237003A (zh) * | 2019-07-10 | 2019-09-17 | 西双版纳宝翠香莲生物科技有限公司 | 一种香水莲花提取物及其在护肤品中的应用 |
CN110251433A (zh) * | 2019-07-11 | 2019-09-20 | 广州栋方生物科技股份有限公司 | 一种香水莲花提取物及其制备方法、包含其的香水莲花水以及莲花保湿舒敏水 |
CN110420143A (zh) * | 2019-08-28 | 2019-11-08 | 青蛙王子(福建)婴童护理用品有限公司 | 一种含有九品香水莲花提取物的凝露及其制备方法 |
KR102167786B1 (ko) * | 2020-07-28 | 2020-10-19 | 주식회사 토리든 | 락토바실러스를 이용한 병풀, 접시꽃, 푸른연꽃, 쓴풀 화장료용 발효물 및 그 제조방법과 화장료용 발효물을 함유한 상처치유, 피부 재생, 진정, 및 항염 효능을 갖는 화장료 조성물 |
CN112168727A (zh) * | 2020-09-29 | 2021-01-05 | 上海怡宝化妆品集团有限公司 | 一种含有灵芝子实体孢子粉发酵液的精华及其制备方法 |
Non-Patent Citations (3)
Title |
---|
HUI-MIN LIU ET AL.,: ""Optimization of Ultrasound-Assisted Cellulase Extraction from Nymphaea hybrid Flower and Biological Activities: Antioxidant Activity, Protective Effect against ROS Oxidative Damage in HaCaT Cells and Inhibition of Melanin Production in B16 Cells"", 《MOLECULES》, vol. 27, no. 6, pages 1 - 23 * |
REHEBATI NUERXIATI ET AL.,: ""Effects of different chemical modifications on the structure and biological activities of polysaccharides from Orchis chusua D. Don"", 《JOURNAL OF FOOD SCIENCE》, vol. 86, no. 6, pages 2434 - 2444 * |
杭书勤 等: ""香水莲花活性成分及其功效的研究进展"", 《山东化工》, vol. 50, no. 20, pages 48 - 49 * |
Also Published As
Publication number | Publication date |
---|---|
CN114917160B (zh) | 2023-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108403498B (zh) | 一种纳豆提取液的制备方法及其应用 | |
CN110946813B (zh) | 一种含燕窝的复合发酵提取物及其制备方法和应用 | |
CN112080543A (zh) | 一种具有抗衰老功效的植物源多肽、含有其的面霜及制备方法 | |
CN113384506B (zh) | 一种低刺激性植物酵素美白纳米组合物和制备方法及其应用 | |
CN108042436B (zh) | 蓝铜胜肽抗衰保湿精华霜 | |
CN111135123B (zh) | 一种卷柏发酵提取液的制备方法和应用 | |
CN117045547A (zh) | 一种抗氧化紧致超分子复合茶发酵提取物的制备方法及应用 | |
CN113402626A (zh) | 一种香水莲花多糖提取物及其制备方法和应用 | |
CN115414290B (zh) | 一种具有保湿、抗氧化、抗炎功效的中药组合物及其制备和应用 | |
CN114917160A (zh) | 一种具有抗氧化、抗炎、修护功效的香水莲花发酵物及其制备与应用 | |
KR20160121632A (ko) | 효모 발효 허브 복합체을 이용하여 항산화 효과가 우수하고 저자극인 추출물의 제조 방법 | |
CN116211758A (zh) | 一种龙胆提取物及其制备方法和应用 | |
CN113648254A (zh) | 可用于化妆品的羽扇豆针叶樱桃发酵物及其制备方法 | |
CN108969430B (zh) | 一种西洋参发酵液作为护肤品或护肤品添加剂的应用 | |
CN114231576A (zh) | 罗伊氏乳杆菌在制备植物多糖中的应用 | |
CN112022756A (zh) | 一种含有灵芝子实体孢子粉发酵液的沐浴露及其制备方法 | |
CN117618316B (zh) | 一种发酵组合物、面膜及其制备方法、应用 | |
CN114146040B (zh) | 一种强化皮肤屏障、抗衰老的组合物及其制备方法和应用 | |
KR102303125B1 (ko) | 진세노사이드 함량 및 보존성이 증진된 이중 코팅 홍삼 과립의 제조방법 | |
CN116650380B (zh) | 一种改善皮肤微循环的抗衰老茶叶发酵产品及其制备方法和应用 | |
KR102642230B1 (ko) | 흑미강발효분말 정제분획을 유효성분으로 포함하는 천식 치료용 조성물 | |
CN114224800B (zh) | 一种蔷薇属植物提取物及其制备方法、组合物及应用 | |
CN111888293B (zh) | 一种含有玫瑰发酵液的保湿爽肤水及其制备方法 | |
CN112315867B (zh) | 一种五味子胶红酵母发酵提取物及其制备方法和应用 | |
CN115645330B (zh) | 一种天竺葵提取物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20220819 Assignee: Fujian Herun Supply Chain Management Co.,Ltd. Assignor: FROG PRINCE (FUJIAN) BABY CARE PRODUCTS Co.,Ltd. Contract record no.: X2023980050787 Denomination of invention: A kind of perfume lotus fermentation with antioxidant, anti-inflammatory and repair effects and its preparation and application Granted publication date: 20230908 License type: Common License Record date: 20240125 |
|
EE01 | Entry into force of recordation of patent licensing contract |